2701 OLYMPIC BOULEVARD, SANTA MONICA, CA
Reports Second Quarter 2026 Results: Pharma Direct and Subscription Revenue Increased 76% and 39%, Respectively, Year-Over-Year
CFO Transition - Christopher McGinnis to Depart GoodRx Holdings
GoodRx Holdings, Inc. Annual Meeting Results - June 16, 2026
Reports First Quarter 2026 Results: Pharma Direct Revenue Increased 82% Year-Over-Year in the First Quarter
Annual Report to Security Holders
Chief Accounting Officer Appointment - Thomas Chan Joins GoodRx Holdings
Director Resignation - Ian T. Clark Steps Down from Board
Chief Accounting Officer Resignation - Romin Nabiey Steps Down
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Additional Proxy Materials
Definitive Proxy Statement
Amended Schedule 13D - Ownership Report
Statement of Changes in Beneficial Ownership
Notice of Proposed Sale of Securities
Initial Statement of Beneficial Ownership